Plasmodium vivax malaria in Sri Lanka: transmission, disease and immunity.
We have established a study site in a malaria endemic region around Kataragama in the south of Sri Lanka. A population of about 3,000 individuals in a group of villages around Kataragama have been provided with access to a small field clinic enabling us to monitor aspects of malarial infection under conditions of natural transmission. At the present time, both Plasmodium falciparum and Plasmodium vivax are prevalent to a similar degree although prior to about five years ago P. falciparum had been virtually absent for most of the previous ten years.
Carter
R
R
Division of Biological Sciences, University of Edinburgh, UK.
David
P
P
Mendis
K
K
D000818:Animals; D000913:Antibodies, Protozoan / Q000097:blood; D000953:Antigens, Protozoan / Q000235:genetics / Q000276:immunology; D016207:Cytokines / Q000502:physiology; D015723:Gene Library; D006801:Humans; D017780:Malaria Vaccines; D016780:Malaria, Vivax / Q000453:epidemiology* / Q000276:immunology / Q000635:transmission; D010966:Plasmodium vivax / Q000235:genetics / Q000276:immunology*; D013188:Sri Lanka / Q000453:epidemiology
D000913:Antibodies, Protozoan; D000953:Antigens, Protozoan; D016207:Cytokines; D017780:Malaria Vaccines